Results 31 to 40 of about 3,028,209 (373)
Role of contrast-enhanced ultrasound (CEUS) in paediatric practice: an EFSUMB position statement [PDF]
, 2016 The use of contrast-enhanced ultrasound (CEUS) in adults is well established in many different areas, with a number of current applications deemed off-label, but the use supported by clinical experience and evidence.
Cantisani, Vito +12 more
core +1 more source
GMS Medizinische Informatik, Biometrie und Epidemiologie, 2013 [english] Background: Lenalidomide, a derivate of thalidomide, in combination with dexamethasone is indicated for the treatment of multiple myeloma in patients who have received at least one prior therapy.
Dörks, Michael +4 more
doaj +1 more source
Off-label use of vaccines [PDF]
Vaccine, 2017 This article reviews the off-label recommendations and use of vaccines, and focuses on the differences between the labelled instructions on how to use the vaccine as approved by the regulatory authorities (or "label"1), and the recommendations for use issued by public health advisory bodies at national and international levels.
Neels, Pieter +8 more
openaire +3 more sources
Off-label Utilization of Antihypertensive Medications in Children [PDF]
, 2007 Objective— To examine off-label utilization and costs of antihypertensive drugs in children using a national sample of prescription claims. Design— Cross-sectional study.
Albert Rocchini +21 more
core +1 more source
OFF-LABEL PEDIATRIC DRUG USE IN INDONESIA : A SYSTEMATIC REVIEW
Jurnal Farmasi Sains dan Praktis, 2020 The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions.
Dewi Latifatul Ilma +1 more
doaj +1 more source
Research Status on Off-label Use in Appraisal for Medical Malpractice [PDF]
Fayixue Zazhi, 2018 Off-label use is widely happened in medical practice. But for now, there is no clear legalistic demarcation for the behaviour of off-label use. Even in medical and legal fields, the consensus has not been reached.
LENG Bing-ning, WANG Xu
doaj +1 more source
Journal of Pediatric and Neonatal Individualized Medicine, 2014 The lack of specific drugs and labelling recommendations for the neonatal population is a long-standing problem throughout the world. With the introduction of the Paediatric Regulation in 2007, in Europe tangible steps have been made to increase clinical
Laura Cuzzolin
doaj +1 more source
Off-label drug use in an adult intensive care unit of a Brazilian hospital [PDF]
Brazilian Journal of Pharmaceutical Sciences, 2023 The objective of this study was to determine the prevalence and describe the factors associated with off-label drug use in an adult intensive care unit (ICU) of a Brazilian hospital.
Elana Figueiredo Chaves +8 more
doaj +1 more source
Acta Medica Bulgarica, 2017 Despite the increasingly strict legislation on medicinal products, the „off-label use“ or „use of medicinal product outside the approved summary of product characteristics (SmPC)“ is a weak point of today’s drug regulation and raises many questions about
Drenska M., Getov I.
doaj +1 more source
ZVT im AMNOG: jetzt neu mit Off-Label-Use?
Monitor Versorgungsforschung, 2023 Das AMNOG ist bekanntlich ein „lernendes System“. Doch in manchen Fällen wird dem System eine Lektion erteilt. So durch das Bundessozialgericht (BSG) im Februar 2023 im sogenannten Regadenoson-Urteil: Der Beschluss des G-BA zu diesem Wirkstoff wurde für ...
Dr. PH Andrej Rasch
doaj +1 more source